Themasap Khan invests in early-stage biotech and health-tech companies (Series Seed to IPO) with check sizes ranging. See sector focus and contact routes.
Themasap Khan invests in early-stage biotech and health-tech companies (Series Seed to IPO) with check sizes ranging from $100K to $5.0M, focusing on genomics, diagnostics, digital health, AI, and regenerative medicine. As a key investor at Civilization Ventures, he backed notable portfolio companies including Rewrite Therapeutics, BillionToOne, Foresight Diagnostics, and Infinimmune. His distinctive thesis centers on being the first-money lead investor for "non-hype-cycle" categories and supporting young PhD/postdoc founders through the firm’s pioneering Fellowship program.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in San Francisco.
Investors like Themasap Khan · Full investor directory · Investor access · Company funding database